| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/13/2010 | CA2347713C Contulakin-g, analogs thereof and uses therefor |
| 07/13/2010 | CA2345932C Peptide-based carrier devices for stellate cells |
| 07/08/2010 | WO2010078325A2 Natriuretic polypeptides for reducing or preventing restenosis |
| 07/08/2010 | WO2010078285A2 Pharmaceutical compositions and methods of treating neurological insults |
| 07/08/2010 | WO2010077928A2 Flavononol renin inhibitor compounds and methods of use thereof |
| 07/08/2010 | WO2010077693A2 Method for identifying agents for inhibiting cell motility and invasiveness |
| 07/08/2010 | WO2010077686A1 Isoindolinone and related analogs as sirtuin modulators |
| 07/08/2010 | WO2010077586A1 N-(1-phenyl-2-arylethyl)-4,5-dihydro-3h-pyrrol-2-amine compounds as subtype selective modulators of alpha2b or alpha2b and alpha2c adrenoceptors |
| 07/08/2010 | WO2010077364A2 Stroke-generated angiogenesis enhancers and uses thereof |
| 07/08/2010 | WO2010077339A2 β-ARRESTIN EFFECTORS AND COMPOSITIONS AND METHODS OF USE THEREOF |
| 07/08/2010 | WO2010077152A1 Biological oil composition, formulations comprising the oil composition, and use thereof to prevent or treat cardiovascular disease |
| 07/08/2010 | WO2010077101A2 Novel thiazolidinedione derivative and use thereof |
| 07/08/2010 | WO2010076248A1 Use of lna apob antisense oligomers for the treatment of acute coronary syndromes |
| 07/08/2010 | WO2010075937A1 Monohydrate of 4-({(4-carboxybutyl)[2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl]-amino}methyl)benzoic acid |
| 07/08/2010 | WO2010075930A1 Modification i of 4-({4-carboxybutyl)[2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl]-amino}methyl)benzoic acid |
| 07/08/2010 | WO2010056527A3 B-biphenyl sulfonamide compounds as ion channel modulators |
| 07/08/2010 | WO2010045575A3 Compositions and methods for treatment of renin-angiotensin aldosterone system (raas)-related disorders |
| 07/08/2010 | WO2010037054A3 Heteroaryl antagonists of prostaglandin d2 receptors |
| 07/08/2010 | WO2010007169A9 Pharmaceutical compositions comprising lignans and their derivatives for treating hyperplastic diseases |
| 07/08/2010 | US20100174076 Coumarin derivatives useful as tnf alpha inhibitors |
| 07/08/2010 | US20100173992 Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use |
| 07/08/2010 | US20100173983 Method for inducing autophagy |
| 07/08/2010 | US20100173972 Methods and uses related to rhbdl4 |
| 07/08/2010 | US20100173970 C-nitroso-derived nitroxyl donors |
| 07/08/2010 | US20100173967 Use of spiro-oxindole compounds as therapeutic agents |
| 07/08/2010 | US20100173961 Benzooxazol-2-one derivatives as lipase and phospholipase inhibitors |
| 07/08/2010 | US20100173956 Use of Quaternary Pyridinium Salts as Vasoprotective Agents |
| 07/08/2010 | US20100173952 Metalloprotein inhibitors |
| 07/08/2010 | US20100173942 Phosphodiesterase 4 inhibitors |
| 07/08/2010 | US20100173925 Oxyindole derivatives |
| 07/08/2010 | US20100173919 Pharmaceutical composition using aliskiren and avosentan |
| 07/08/2010 | US20100173916 Xanthine Derivatives, the Preparation Thereof and Their Use as Pharmaceutical Compositions |
| 07/08/2010 | US20100173915 Pharmaceutical compositions for the treatment of chronic heart failure comprising pyrazolopyrimidinone derivative compound |
| 07/08/2010 | US20100173899 Dipeptide analogs as coagulation factor inhibitors |
| 07/08/2010 | US20100173895 Imidazolopyrimidines and imidazolotriazine derivatives as inhibitors of poly(adp-ribose)polymerase(parp) |
| 07/08/2010 | US20100173894 Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| 07/08/2010 | US20100173886 Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders |
| 07/08/2010 | US20100173883 7-hydroxyepiandrosterone having neuroprotective activity |
| 07/08/2010 | US20100173878 Organic compounds |
| 07/08/2010 | US20100173876 Oil-based nsaid compositions and methods for making and using same |
| 07/08/2010 | US20100173870 Phosphonate Compounds |
| 07/08/2010 | US20100173848 Methods of inhibiting chemokine binding to chemokines receptors |
| 07/08/2010 | US20100173827 Role of proline rich peptides in cellular communication mechanisms and treatment of diseases |
| 07/08/2010 | US20100173826 Smooth Muscle Relaxation |
| 07/08/2010 | US20100173824 Azepinoindole Derivatives As Pharmaceutical Agents |
| 07/08/2010 | US20100173823 Alpha2c adrenoreceptor agonists |
| 07/08/2010 | US20100173025 Fat absorption inhibitory composition |
| 07/08/2010 | US20100173008 Method of treating or alleviating the symptoms of alesion in mammal |
| 07/08/2010 | US20100173002 Microcapsules with improved shells |
| 07/08/2010 | US20100172995 Process For Preparing A Solid Pharmaceutical Composition |
| 07/08/2010 | US20100172991 Extended Release Formulation and Methods of Treating Adrenergic Dysregulation |
| 07/08/2010 | US20100172971 Compositions for Inhibiting NADPH Oxidase Activity |
| 07/08/2010 | US20100172966 Methods and compositions for cellular reprogramming |
| 07/08/2010 | US20100172963 Medicinal agent for treating patients suffering from diseases caused by the monoaminooxidase excessive activity and a method for treating patients suffering |
| 07/08/2010 | US20100172930 Transfection complexes |
| 07/08/2010 | US20100172902 Method for treating a vcam-1 mediated disease |
| 07/08/2010 | US20100172897 Diagnosis and Prevention of Fetal Heart Disease |
| 07/08/2010 | US20100172896 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| 07/08/2010 | US20100172890 Agmatine containing dietary supplements, nutraceuticals, and foods |
| 07/08/2010 | US20100172884 Cardiac Muscle Repair Or Regeneration Using Bone Marrow-Derived Stem Cells |
| 07/08/2010 | CA2750153A1 Biological oil composition, formulations comprising the oil composition, and use thereof to prevent or treat cardiovascular disease |
| 07/08/2010 | CA2748811A1 Stroke-generated angiogenesis enhancers and uses thereof |
| 07/08/2010 | CA2748411A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof as hif activators |
| 07/08/2010 | CA2748340A1 .beta.-arrestin effectors and compositions and methods of use thereof |
| 07/08/2010 | CA2746871A1 Monohydrate of 4-({(4-carboxybutyl)[2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl]-amino}methyl)benzoic acid |
| 07/08/2010 | CA2746870A1 Modification i of 4-({4-carboxybutyl)[2-(2-{[4-(2-phenylethyl)benzyl]oxy}phenyl)ethyl]-amino}methyl)benzoic acid |
| 07/08/2010 | CA2746295A1 N-(1-phenyl-2-arylethyl)-4,5-dihydro-3h-pyrrol-2-amine compounds as subtype selective modulators of alpha2b or alpha2b and alpha2c adrenoceptors |
| 07/08/2010 | CA2746221A1 Isoindolinone and related analogs as sirtuin modulators |
| 07/07/2010 | EP2204181A2 Protease inhibitors |
| 07/07/2010 | EP2203411A2 N-phenyl anthranilic acid derivatives and uses thereof |
| 07/07/2010 | EP2203070A2 Pomegranate extracts, nutritional products containing them and their uses |
| 07/07/2010 | EP2203061A1 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 07/07/2010 | EP2010921B1 Method for diagnosing cardiovascular diseases |
| 07/07/2010 | EP1873153B1 3-azetidinecarboxylic acid derivatives for use as immunosuppressants |
| 07/07/2010 | EP1708692B1 Dichloroacetate in combination with an inotrope for cardioprotection |
| 07/07/2010 | EP1491537B1 Hydroxymorpholinone derivative and medicinal use thereof |
| 07/07/2010 | EP1487806B1 4-anilino quinazoline derivatives as antiproliferative agents |
| 07/07/2010 | EP1485099B1 Inhibitors of histone deacetylase |
| 07/07/2010 | EP1334201B1 Dna expression vectors |
| 07/07/2010 | EP1274834B1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 07/07/2010 | CN1942469B Condensed pyridine derivatives useful as A28 adenosine receptor antagonists |
| 07/07/2010 | CN1907320B Traditional Chinese medicine compound, processes for preparing traditional Chinese medicine therefrom and use thereof |
| 07/07/2010 | CN101772494A 4-pyrimidinesulfamide derivative |
| 07/07/2010 | CN101768614A Method for efficiently extracting polysaccharide and polyphenol from agaricus blazei |
| 07/07/2010 | CN101768209A Hypotensive peptide with high in-vivo activity and preparation and purification method thereof |
| 07/07/2010 | CN101768202A Preparing method of high purity sarsasapogenin in rhizoma anemarrhenae and derivatives thereof, and medical new application thereof |
| 07/07/2010 | CN101768153A Method for preparing israbipine medicament for treating hypertension |
| 07/07/2010 | CN101768148A New preparation method of hydrochloride landiolol |
| 07/07/2010 | CN101768146A Method for preparing benzoyl-flavone |
| 07/07/2010 | CN101768145A Nitric oxide-donating chrysin derivatives, preparation method thereof, medical use thereof |
| 07/07/2010 | CN101768128A Method for refining Valsartan containing more than 10% of isomer |
| 07/07/2010 | CN101768108A Pyridine ring-substituted alpha-hydroxycarboxylic acid derivatives, preparation method thereof and use thereof |
| 07/07/2010 | CN101768080A Medicinal compound and medicinal use thereof |
| 07/07/2010 | CN101768079A Compound and medicinal application thereof |
| 07/07/2010 | CN101766811A Application of exenatide acetate or analogue thereof in preparing drug for treating or preventing diabetes complicated with cerebral infarction |
| 07/07/2010 | CN101766799A Ginseng-monkshood centipede health wine |
| 07/07/2010 | CN101766788A Pharmaceutical composite for treating cerebrovascular diseases |
| 07/07/2010 | CN101766761A Traditional Chinese medicine formula for treating and stabilizing blood pressure and preparation method thereof |
| 07/07/2010 | CN101766759A Medicinal footbath liquor |
| 07/07/2010 | CN101766753A Vitality source capsule and preparation method thereof |